Transaction in Own Shares

Summary by AI ^BETAClose X

McBride plc has purchased 5,048 of its ordinary shares on December 12, 2025, through Investec Bank plc, with prices ranging from 128.80 pence to 130.20 pence, and a weighted average of 129.8452 pence. These shares will be cancelled as part of the company's ongoing buyback program. Following this transaction, McBride plc will have 177,635,646 ordinary shares in issue, with the total number of voting rights now standing at this figure. The percentage of voting rights held in treasury is 0.02 percent.

Disclaimer*

McBride PLC

15 December 2025

McBride plc

Transaction in Own Shares

McBride plc (the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each ("Ordinary Shares") through Investec Bank plc (the "Broker").

Ordinary Shares

Date of purchase:	12^th December 2025
Number of ordinary shares purchased:	5,048
Lowest price per share (pence):	128.80
Highest price per share (pence):	130.20
Weighted average price per day (pence):	129.8452

The Company will purchase the above Ordinary Shares through the Broker on the London Stock Exchange (the "Purchases") and will subsequently cancel them.

Such Purchases form part of the Company's existing buyback programme and were effected pursuant to the non-discretionary agreement entered into with the Broker, as announced on 1^st December 2025.

Following the Purchases and cancellation of these Ordinary Shares, the Company will have 177,635,646 Ordinary Shares in issue (excluding treasury shares), hold 42,041 Ordinary Shares in treasury, and have 594,610,458 non-cumulative redeemable preference shares of 0.1 pence each in the Company ("B Shares") in issue. B Shares carry no rights to attend, speak or vote at Company meetings, except on a resolution relating to the winding up of the Company.

Once the Ordinary Shares are cancelled, the total number of voting rights in the Company will be 177,635,646. This figure may be used by shareholders of the Company as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company pursuant to the Disclosure and Transparency Rules (the "DTRs").

The Company confirms that, in accordance with DTR 5.5.1R, following the Purchases the percentage of voting rights attributable to the Ordinary Shares held in treasury is 0.02 per cent.

The tables below contain detailed information about the Purchases.

Schedule of Purchases:

Issuer name: McBride plc

ISIN: GB0005746358

Date of purchases: 12^th December 2025

Investment firm: Investec Bank plc

Aggregate Information

Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
XLON	129.8452	5,048	128.80	130.20

Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the Broker on behalf of the Company as part of the buyback programme is detailed below:

Date and time of each trade	Number of shares purchased	Price (pence per share)	Trading Venue	Transaction Reference Number
12 December 2025 08:16:02	618	130.20	XLON	00365740366TRLO1
12 December 2025 08:44:21	171	129.60	XLON	00365756805TRLO1
12 December 2025 08:52:18	595	130.20	XLON	00365761398TRLO1
12 December 2025 08:52:18	597	130.20	XLON	00365761404TRLO1
12 December 2025 09:01:52	638	129.60	XLON	00365766840TRLO1
12 December 2025 09:10:50	11	128.80	XLON	00365773250TRLO1
12 December 2025 09:27:16	580	128.80	XLON	00365782951TRLO1
12 December 2025 09:34:37	642	130.20	XLON	00365788355TRLO1
12 December 2025 09:42:40	598	129.80	XLON	00365795205TRLO1
12 December 2025 09:42:40	598	129.80	XLON	00365795206TRLO1

For further information please contact:

McBride plc

Chris Smith, Chief Executive Officer

Mark Strickland, Chief Financial Officer

Instinctif Partners 020 7457 2020

Hannah Scott

Galyna Kulachek

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END